Chemical Peel for Skin Rejuvenation - Quick Reference Sheet

Chemical Peel for Skin Rejuvenation

Created on 09/11/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

Controlled destruction of the skin's outer layers for smoother, more evenly colored skin. Depth decides everything: the shallowest clear roughness, brown patches and acne marks in days; the deepest reshape skin structure for a decade but cost weeks of recovery and possible permanent color change. Evidence is strongest for pigment and precancerous sun spots; wrinkle gains are modest. (Full Review)

Protocol

Superficial glycolic acid peel
20–70% for 2–5 min
Neutralized with sodium bicarbonate; series of 4–6 sessions spaced 2–4 weeks apart
Medium-depth combination peel
Jessner's + 35% trichloroacetic acid
Jessner's solution followed immediately by trichloroacetic acid; alternatives pair it with 70% glycolic acid or solid carbon dioxide
Deep phenol-croton oil peel
Phenol 88%, croton oil 0.1–0.8%
Applied segmentally under sedation, split across cosmetic units at 10–15 minute intervals
Time to effect
Deep peels
3–6 months
Final appearance at 3–6 months; results reported to persist a decade or longer
Medium peels
2–4 weeks
Results 2–4 weeks after re-epithelialization, with dermal remodeling continuing 3–6 months
Superficial peels
6–12 weeks
Visible change after 3–6 sessions across 6–12 weeks

Benefits

Contraindications
  • Within 6 months of oral isotretinoin (medium-depth and deep peels)
  • Active herpes simplex outbreak, bacterial or fungal facial infection
  • Personal or family history of keloid or hypertrophic scarring
  • Fitzpatrick phototype V–VI without an uneventful test spot (medium-depth and deep peels)
  • Documented arrhythmia, corrected QT interval above 470 ms, or ischemic heart disease (phenol peels)
  • QT-prolonging medication: class III antiarrhythmics, macrolide antibiotics, some antipsychotics (phenol peels)
  • Hepatic impairment Child-Pugh Class B or C, or kidney filtration below 60 mL/min/1.73 m² (phenol peels)
  • Uncontrolled diabetes (glycated hemoglobin above 8%)
  • Within 6 months of facial radiotherapy, facial surgery or ablative laser resurfacing
  • Pregnancy or breastfeeding (any peel beyond very superficial alpha-hydroxy acid)
  • Active connective-tissue disease affecting wound healing, or body dysmorphic disorder
Key Interactions
  • Topical retinoids (tretinoin, adapalene, tazarotene)
  • Photosensitizing prescription medication (doxycycline, ciprofloxacin, hydrochlorothiazide, amiodarone)
  • Hormonal contraceptives and hormone therapy
  • Over-the-counter salicylate products (aspirin, salicylate rubs, acne washes)
  • Over-the-counter hydroquinone and azelaic acid (additive benefit)
  • Supplements with additive photosensitivity (St John's wort, high-dose niacin, bergamot or citrus essential oils)
  • Supplements affecting bleeding and healing (fish oil, high-dose vitamin E, ginkgo, garlic extract)
  • Supplements with additive pigment benefit (oral tranexamic acid, Polypodium leucotomos)
  • Other procedural interventions (microneedling, fractional laser, photodynamic therapy)

Risk & Side Effects

  • High: Post-inflammatory hyperpigmentation; transient erythema, stinging and desquamation
  • Medium: Scarring; treatment failure requiring repeat courses
  • Low: Impaired healing after recent isotretinoin; herpes simplex reactivation; persistent hypopigmentation and demarcation lines; phenol systemic toxicity; systemic toxicity from salicylic acid and resorcinol; post-procedure infection and milia
  • Speculative: Mutagenic potential of phenol

Monitoring

Marker Target Why
Fitzpatrick skin phototype I–III for medium and deep peels; IV–VI superficial only unless test-spotted Predicts rebound darkening
Glogau photoaging grade II–III for medium peels; IV needs a deep peel or laser Sets achievable depth and expectation
Electrocardiogram (ECG) and corrected QT interval Sinus rhythm; QTc below 440 ms in men and 460 ms in women Phenol provokes arrhythmia
Serum creatinine and eGFR eGFR above 90 mL/min/1.73 m² Phenol is cleared by the kidneys
ALT and AST ALT 10–26 U/L in men, 8–22 U/L in women; AST 10–26 U/L Phenol is conjugated in the liver
Glycated hemoglobin (HbA1c) Below 5.4% High blood glucose delays wound closure
Methemoglobin by co-oximetry Below 1.5% Resorcinol in Jessner's solution can raise it
Serum salicylate Undetectable, below 2 mg/dL Large-area salicylic acid peeling can cause salicylism
25-hydroxyvitamin D 40–60 ng/mL Strict light avoidance during healing suppresses skin synthesis
Herpes simplex virus IgG serostatus No established target value; serostatus and prophylaxis adherence are tracked instead Identifies who is at reactivation risk

Cadence: Review at 48–72 hours, 2 weeks, 6–8 weeks, then 3 and 6 months; thereafter every 6–12 months. Laboratory values repeated only for phenol peels, immediately after the procedure and at 24 hours.

Qualitative Assessment

  • Time for redness to settle to baseline, compared with what was predicted for the depth used
  • Whether make-up coverage is still needed for pigment at 8 weeks
  • Self-rated skin texture and radiance, recorded on the same scale before and 3 months after
  • Whether the treated area still reads as a distinct zone against untreated neck and chest
  • Confidence in unretouched photographs taken at fixed distance and lighting
  • Whether the downtime already taken feels proportionate to the change achieved, before booking another session